Non-Hodgkin Lymphoma


Combo improves PFS in untreated CLL

Results of a phase 3 study suggest that adding ofatumumab to chlorambucil can improve progression-free survival (PFS) in treatment-naïve patients...


Inhibitor controls WM long-term

Photo by Sam Odgen Updated results of a phase 2 trial suggest the Bruton’s tyrosine kinase inhibitor ibrutinib can control Waldenstrom’s...


Immunotherapy gets orphan designation

Photo by Graham Colm The US Food and Drug Administration (FDA) has granted orphan designation to an immunotherapy known as CMD-003, which is...


Pesticides may cause NHL, other cancers

Photo by John Messina The International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization, has...